Biopharma
Some Likely Winners In the Post-Covid World (Part Two: Healthcare Transformation)
As we noted last week, some of the social and economic changes wrought by the covid pandemic will be enduring and not just transitory. Many companies well-positioned to benefit from these new or newly strengthened themes have seen their stocks outperform in the year so far, and although volatility certainly Read more…